{"product_id":"xamamina-mal-di-viaggio-50mg-6-capsule-molli","title":"Xamamina Travel Sickness 50mg 6 softgels","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSeasickness, plane sickness, car sickness and train sickness.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eXAMAMINA TRAVEL SICKNESS 50 mg soft capsules \u003c\/b\u003e One soft capsule contains: active ingredient: dimenhydrinate 50 mg Excipients: sorbitol, parabens \u003cb\u003eXAMAMINA TRAVEL SICKNESS Children 25 mg soft capsules\u003c\/b\u003e One soft capsule contains: active substance: dimenhydrinate 25 mg Excipients: sorbitol, parabens For the complete list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eXAMAMINA TRAVEL SICK 50 mg soft capsules and XAMAMINA TRAVEL SICK \u003c\/b\u003e \u003cb\u003eChildren 25 mg soft capsules\u003c\/b\u003e macrogol 400. Shell: gelatin; \u003cb\u003epartially dehydrated liquid sorbitol; sodium-ethyl parahydroxybenzoate (E215); sodium propyl parahydroxybenzoate (E 217)\u003c\/b\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance, to other antihistamines or to any of the excipients. Contraindicated in children under 2 years of age. Contraindicated during pregnancy and breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eXAMAMINA TRAVEL SICKNESS 50 mg soft capsules \u003c\/b\u003e In adults 1 soft capsule half an hour before travel; if necessary repeat the dose after 3-4 hours, up to a maximum of 4 soft capsules in 24 hours. \u003cb\u003eXAMAMINA TRAVEL SICKNESS Children 25 mg soft capsules\u003c\/b\u003e In children aged between 2-6 years 1 soft capsule of Xamamine Travel Sickness Children half an hour before travel up to a maximum of 3 times in 24 hours. In children aged between 7-12 years 1-2 soft capsules of Xamamine Travel Sickness Children half an hour before travel, up to a maximum of 2-3 times in 24 hours. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore at a temperature not exceeding 25°C\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product must be administered with caution in subjects suffering from closed-angle glaucoma, prostatic hypertrophy, urinary retention, slowed intestinal transit, bronchial asthma, epilepsy, porphyria. The product can mask the symptoms of ototoxicity and therefore must be administered with caution in patients receiving ototoxic drugs. The soft capsules contain \u003ci\u003esorbitol\u003c\/i\u003e: Patients suffering from rare hereditary problems of fructose intolerance should not take this medicine. The soft capsules contain \u003ci\u003eparabens\u003c\/i\u003e which can cause allergic reactions (even delayed).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product may increase the effects of other Central Nervous System depressants, such as alcohol, barbiturates, other hypnotics, sedatives or tranquilizers. In case of concomitant intake of these substances, care must be taken to avoid additive sedation phenomena. The product may enhance the effects of other anticholinergic drugs, including antidepressants. If administered concomitantly with aminoglycoside antibiotics or other ototoxic drugs, dimenhydrinate can mask the first symptoms of ototoxicity, which can only be detected when the damage is irreversible (see also par. 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following side effects have been reported following treatment with Xamamine Travel Mal:\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders - Frequent side effects: Anorexia.\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders - Less frequent side effects: Insomnia (especially in children) Euphoria.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders - Most frequent side effects: Sedation Drowsiness. Frequent side effects: Headache. Less frequent side effects: Dizziness Tremors Convulsions (especially in children).\u003c\/p\u003e\n\u003cp\u003eVision disorders - Frequent side effects: Accommodation disorders.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders - Less frequent side effects: Tachycardia.\u003c\/p\u003e\n\u003cp\u003eVascular disorders - Less frequent side effects: Hypotension.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequent side effects: Dry mouth Nausea.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Frequent side effects: Photosensitivity Allergic skin reaction.\u003c\/p\u003e\n\u003cp\u003eKidney and urinary disorders - Frequent side effects: Micturition disorders.\u003c\/p\u003e\n\u003cp\u003eGeneral disorders and administration site conditions - Less frequent side effects: Asthenia.\u003c\/p\u003e\n\u003cp\u003e\"Reporting suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of overdose, consult your doctor immediately. Drowsiness is the most usual symptom of overdose. Toxic doses can produce: convulsion, coma and respiratory depression. If necessary, implement symptomatic therapy. When necessary, respiratory assistance.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e. In reproduction studies in rats and rabbits, doses 20-25 times higher than those normally used in human therapy did not show any teratogenic effects or reduction in fertility. However, no data are available on the use of the product in pregnant women. Therefore, although the teratogenicity of the product appears unlikely, the use of dimenhydrinate during pregnancy is contraindicated. \u003cu\u003eBreastfeeding\u003c\/u\u003e. Small amounts of dimenhydrinate pass into breast milk. Given the possible adverse events of the product in newborns, the use of dimenhydrinate during breastfeeding is contraindicated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince the most frequent side effect of antihistamines is sedation which can manifest itself as drowsiness, this must be taken into account by those who carry out operations requiring an intact level of vigilance (driving motor vehicles, operating machinery).\u003c\/p\u003e","brand":"Dompé","offers":[{"title":"Default Title","offer_id":51131230093639,"sku":"002955060","price":8.84,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/dompe-farmaceutici-spa-xamamina-mal-di-viaggio-50mg-6-capsule-molli-farmacia-dottor-tili-1213792326.jpg?v=1767143148","url":"https:\/\/www.dottortili.com\/en-eu\/products\/xamamina-travel-mal-50mg-6-soft-capsules","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}